I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
AD80 HAS HIGHER POTENCY COMPARED TO CLINICALLY USED FLT3 IN..:
Miranda, LBL
;
Rossini, NO
;
Lima, K
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S220 , 2023
Link:
https://doi.org/10.1016/j.htct.2023.09.457
RT Journal T1 <Title>AD80 HAS HIGHER POTENCY COMPARED TO CLINICALLY USED FLT3 INHIBITORS IN FLT3-ITD AML CELLS</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.htct.2023.09.457&Exemplar=1&LAN=DE A1 Miranda, LBL A1 Rossini, NO A1 Lima, K A1 Pereir-Martins, DA A1 Schuringa, JJ A1 Rego, EM A1 Traina, F A1 Dias, MVB A1 Machad-Neto, JA PB Elsevier BV YR 2023 SN 2531-1379 JF Hematology, Transfusion and Cell Therapy VO 45 SP S220 LK http://dx.doi.org/https://doi.org/10.1016/j.htct.2023.09.457 DO https://doi.org/10.1016/j.htct.2023.09.457 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
